Recon

LimaCorporate Celebrates the Launch of the SMR TT Hybrid Glenoid, Expanding the Shoulder Portfolio

UDINE, Italy, November 30, 2018 /PRNewswire/ -- LimaCorporate is pleased to announce the launch of the SMR TT Hybrid Glenoid, the latest addition to the SMR Shoulder System. The SMR Shoulder System is a total shoulder replacement designed to provide surgeons a wide range of options to address the different patients' pathologies. There have been over 150,000 implants

By |2018-11-30T15:37:18+00:00November 30th, 2018|Recon, Top Stories|

Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery

PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT Revision Total Ankle Replacement System. “Integra’s new total ankle revision system is designed to provide surgeons with stable tibial fixation through a narrow, finned tibia. I appreciate

By |2018-11-21T16:48:34+00:00November 21st, 2018|Recon|

Patients with shoulder arthritis have new options to avoid risks of total shoulder replacement

ROSEMONT, Ill., Nov. 16, 2018 /PRNewswire/ -- A new review article published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) finds arthroscopic (joint replacement or reconstruction) management could be a promising option for young, active patients diagnosed with GHOA. Primary glenohumeral osteoarthritis (GHOA) is a common type of painful and debilitating shoulder osteoarthritis (OA). Shoulder OA leads to upper

By |2018-11-19T20:27:14+00:00November 19th, 2018|Recon|

Smith & Nephew Presents Excellent Results for JOURNEY™ II Total Knee at the 2018 American Association of Hip and Knee Surgeons

MEMPHIS, Tenn., Nov. 16, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, presented a number of compelling clinical outcomes around its flagship JOURNEY II BCS knee earlier this month at the American Association of Hip and Knee Surgeons (AAHKS). The announcement follows more than a dozen publications during the past year from

By |2018-11-16T20:52:16+00:00November 16th, 2018|Recon|

OSN Interview with David Derminio – Executive Vice President Commercialization at Myoscience

Dave, would you please give us a brief overview of your Orthopedic career and how you got started in the business? Immediately following my graduation from the Business School at Arizona State University I went to work for American Hospital Supply Corporation. As I progressed through my career with AHSC, they provided excellent training in

By |2018-11-15T18:00:15+00:00November 15th, 2018|Recon|

Spokane Doctor Advancing Performance of Total Knee Replacements

SPOKANE, Wash., Nov. 13, 2018 /PRNewswire/ -- Dr. David F. Scott, a leading orthopedic surgeon and researcher, is exploring new, innovative knee implant designs and surgical techniques made for custom fit total knee replacements. The basis for this improved knee replacement performance is an anatomical approach, whereby an implant is placed in the native joint line of a patient's

By |2018-11-14T18:14:28+00:00November 14th, 2018|Recon|

Implanet: Partnership Agreement with KICO KNEE INNOVATION COMPANY PTY LTD for the MADISON Knee Prosthesis in the United States and Other Future Markets

November 13, 2018 BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee surgery implants, is announcing a distribution agreement with privately owned KICO KNEE INNOVATION COMPANY PTY LTD (“KICO”) for the MADISON Knee prosthesis business covering the

By |2018-11-14T16:09:54+00:00November 14th, 2018|Recon|

Reduce Revisions Initiative Launched to Promote Best Practices for Total Joint Replacement Surgery

YARDLEY, Penn., Nov. 12, 2018 /PRNewswire/ -- Today marked the launch of the Reduce Revisions Initiative (www.reducerevisions.org), a program focused on supporting orthopedic professionals with the goal of measurably improving outcomes of total joint arthroplasty (TJA). Total Joint Arthroplasty can dramatically improve lives by restoring mobility, reducing pain, and promoting a return to normal activities. Most of

By |2018-11-13T16:20:12+00:00November 13th, 2018|Recon|

EOS imaging to Present Its EOSapps Suite at the French Society of Orthopedic and Traumatological Surgery Congress (SOFCOT)

November 12, 2018 PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging  (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a pioneer in 2D/3D orthopedic medical imaging, will present its EOSapps solution with particular focus on hipEOS 3.0 online surgical planning software at the French Society of Orthopedic and Traumatological Surgery (SOFCOT) Congress, being held November 12-15,

By |2018-11-12T18:12:35+00:00November 12th, 2018|Recon|

OsteoRemedies® Announces the First FDA Cleared Dual-Antibiotic Spacer and Bone Cement with Gentamicin and Vancomycin

MEMPHIS, Tenn., Nov. 1, 2018 /PRNewswire/ -- OsteoRemedies®, LLC, a company focused on providing simple solutions to complex disorders, is pleased to announce the launch of the REMEDY SPECTRUM™️ GV Hip Spacer System and SPECTRUM™️ GV Bone Cement.  Building on its portfolio consisting of the only pre-made modular spacer system with Gentamicin for Hip, Knee and Shoulders, the REMEDY

By |2018-11-02T15:43:56+00:00November 2nd, 2018|Recon|